The Alarming Rise in Pediatric Melatonin Overdoses: A Growing Public Health Concern

Originally published February 2025. Last reviewed/updated by Craig Canapari, MD in January 2026.

A stark surge in melatonin overdoses among children has prompted urgent calls for increased parental awareness and potentially stricter regulatory oversight. Data reveals a staggering 530% increase in melatonin ingestions over the past decade, with a particularly accelerated rise observed since the onset of the COVID-19 pandemic. This trend has transformed melatonin into a leading cause of emergency room visits for children under five, raising significant concerns among healthcare professionals and public health officials alike.

Escalating Emergency Room Visits and the Pandemic’s Impact

Recent studies paint a concerning picture of melatonin’s prevalence in pediatric emergency care. An analysis of emergency department visits indicated that approximately 7% of all accidental ingestions in children under the age of five were attributed to melatonin. Alarmingly, nearly half of these incidents involved the ingestion of melatonin gummies, products often designed to resemble candy, increasing the risk of accidental consumption by young children. This surge has led to melatonin becoming the most frequently accidentally ingested supplement among children, a designation it attained in 2020. Experts widely attribute this dramatic increase to the sleep disturbances experienced by many children during the early stages of the pandemic, coupled with the disruptions caused by lockdowns and altered routines.

Key Findings from a Landmark Study on Pediatric Melatonin Ingestions

A pivotal study, "Pediatric Melatonin Ingestions—United States, 2012-2021," published on June 3, 2022, in the MMWR Morb Mortal Wkly Rep, by Lelak and colleagues, meticulously reviewed poison control center data over a ten-year period. The findings underscore the escalating nature of the problem:

• Exponential Increase in Ingestions: The study documented a 530% increase in reported melatonin ingestions between 2012 and 2021. These incidents accounted for 2.25% of all reported ingestions during this timeframe. The proportion of ingestions attributed to melatonin rose from a mere 0.6% in 2012 to a significant 4.9% in 2021. This trend shows a consistent upward trajectory, with a particularly sharp acceleration observed from 2020 onwards.

• Rise in Serious Outcomes: The research also highlighted an increase in more severe outcomes associated with melatonin ingestions. While the overall percentage of ingestions requiring healthcare facility management remained relatively stable, the proportion of those requiring hospitalization and intensive care unit (ICU) stays saw an increase. Notably, the most substantial rise in hospitalizations was observed in children under the age of five, a demographic particularly vulnerable to accidental overdoses.

  

• Tragic Fatalities Reported: The study reported two deaths linked to melatonin ingestions. One involved a 13-month-old infant, and the other a 2-month-old infant. Both incidents occurred at home, with the stated reasons for ingestion being intentional medication misuse in one case and an unknown cause in the other. These represent some of the first reported fatalities associated with melatonin overdoses, underscoring the potential severity of these incidents.

Factors Contributing to the Overdose Epidemic

While the study did not definitively establish the causes for the surge in overdoses, several factors are believed to be contributing to this public health crisis:

• Increased Accessibility and Popularity: Melatonin has become widely available over-the-counter in various forms, including gummies, tablets, and liquids. Its perceived safety and ease of use have led to its widespread adoption by parents seeking to address their children’s sleep difficulties. A visual survey of local drug stores reveals entire shelves dedicated to pediatric melatonin products, many featuring vibrant packaging and child-friendly flavors, further contributing to their appeal and accessibility.

• Marketing and Misinformation: The marketing of melatonin products, particularly gummies, often likens them to candy. This can create a false sense of security for both parents and children, blurring the lines between a dietary supplement and a treat. The lack of robust regulation for supplements in the United States, compared to other countries, means that products are not subject to the same rigorous testing and approval processes as pharmaceuticals.

• The COVID-19 Pandemic’s Impact on Sleep: The unprecedented disruptions to daily life, including school closures, altered schedules, and increased screen time, significantly impacted children’s sleep patterns. Many parents turned to melatonin as a readily available solution to manage their children’s sleep issues, inadvertently increasing the potential for accidental overdoses.

• Lack of Clear Dosing Guidelines: Inconsistent dosing recommendations and a general lack of understanding regarding appropriate melatonin dosages for children contribute to the risk of accidental overconsumption. Parents may administer higher doses than recommended or fail to store the supplements securely, leading to accidental ingestions.

Understanding the Risks and Potential Dangers

While melatonin is generally considered safe when used appropriately, excessive intake can lead to a range of adverse effects. These can include:

• Immediate Symptoms: Drowsiness, dizziness, nausea, vomiting, irritability, and confusion.
• More Severe Reactions: In some cases, significant ingestions have led to delirium, hallucinations, and even seizures.
• Cardiovascular and Metabolic Effects: Melatonin can influence blood pressure and blood sugar levels. This is particularly concerning for children with pre-existing conditions or those taking medications that affect these vital signs.

Drug Interactions and Considerations

It is crucial for parents to be aware of potential drug interactions with melatonin. A pediatric pharmacist, Sasha Dorzin, PharmD, highlights several key interactions:

• Fluvoxamine: This antidepressant can significantly increase melatonin levels in the body.
• Oral Contraceptives: These can increase the production of melatonin.
• Hypnotic Drugs: Concurrent use with other sleep-inducing medications can potentiate sedative effects.
• Blood Pressure and Blood Sugar Medications: Melatonin’s effects on blood pressure and blood sugar necessitate caution when used with medications that also influence these parameters.

Regulatory Landscape: A Global Perspective

The regulatory approach to melatonin varies significantly across the globe, highlighting potential areas for improvement in the United States.

• United States: Melatonin is classified as a dietary supplement. This means it is not subject to pre-market approval by the Food and Drug Administration (FDA). Manufacturers are responsible for ensuring the safety and efficacy of their products, but the FDA does not test new ingredients or supplements before they reach the market. This regulatory framework contributes to the widespread availability and potential variability in product quality and dosage accuracy.

• Canada: Melatonin is regulated as a non-prescription health product under the Food and Drug Regulations. Products must obtain a Natural Product Number (NPN) to be sold, indicating they have met certain safety and quality standards.

• European Union: Regulations are more stringent. While immediate-release melatonin at low doses (under 2 mg) may have variable status depending on the country, sustained-release formulations typically require a prescription. The European Medicines Agency has established specific guidelines for its use.

• United Kingdom: Melatonin is generally available by prescription only.

• Taiwan: Melatonin is classified as a controlled substance, requiring a prescription for access.

  

This global disparity underscores the potential for a more robust regulatory framework in the United States to enhance the safety of melatonin products, particularly those marketed for pediatric use.

When to Seek Medical Help

In the event of a suspected melatonin overdose, parents should immediately contact the national Poison Help Hotline at 1-800-222-1222. Medical professionals are available 24/7 to provide guidance and assistance.

Promoting Safe Melatonin Use in Children

For parents considering or currently using melatonin for their children, adherence to the following guidelines is paramount:

• Consult a Healthcare Professional: Always discuss the use of melatonin with your child’s pediatrician or a sleep specialist. They can help determine if melatonin is appropriate for your child’s specific sleep issues and recommend the correct dosage.
• Strict Storage: Keep melatonin products securely stored out of reach of children, just as you would with any medication or potentially harmful substance.
• Accurate Dosing: Administer only the prescribed or recommended dosage. Do not exceed the recommended amount.
• Read Labels Carefully: Pay close attention to the concentration of melatonin per serving and the total number of servings in the container.
• Understand the Form: Be aware of the form of melatonin (e.g., gummies, liquid, tablet) and its potential for accidental ingestion. Gummies, in particular, require extra vigilance due to their candy-like appearance.
• Educate Children: As children get older, educate them about the importance of not taking medication without adult supervision.

Looking Ahead: A Call for Action

The escalating rates of pediatric melatonin overdoses represent a significant public health challenge. Addressing this issue will likely require a multi-faceted approach. This includes enhanced public awareness campaigns to educate parents about the risks, clearer guidelines for healthcare providers on melatonin prescribing and counseling, and a potential re-evaluation of the regulatory framework for over-the-counter supplements in the United States. The goal is to ensure that melatonin can be used as a beneficial tool for sleep management while mitigating the serious risks associated with its misuse and accidental overdose in children.

For parents seeking further information on melatonin, its mechanisms of action, and evidence-based usage guidelines, comprehensive resources are available. This includes detailed guides that address the benefits, risks, and appropriate administration of melatonin for pediatric populations.

To further empower parents and caregivers with actionable strategies for improving their children’s sleep, resources such as free sleep training mini-courses offer valuable guidance. These programs aim to equip families with the knowledge and tools necessary to foster healthier sleep habits and reduce reliance on supplements when possible.